PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

46,012 stories, page 706 of 767

Advanced search
🌍Industrypsomagen.comTier 1 · Company source

Psomagen Selected as Key Service Provider, Will Utilize Ultima Genomics’ UG 100™ Sequencer to Execute Chan Zuckerberg Initiative’s ‘Billion Cells’ Project

PsomagenOriginal source
🌍Mediacentogene.comTier 2 · Direct publisher

Reproductive Genetics Portfolio Launch: PGT-A and Carrier Services

CentogeneOriginal source
🇹🇷Regulatoryaifd.org.trTier 1 · Regulatory source

Hasta Temsilciliği

AIFD TurkeyOriginal source
🌍Industryintercure.coTier 1 · Company source

Form 6-K-InterCure Announces FY2024 Results and Provides Q1 2025 Update:Revenue of NIS 239 Million and Adjusted EBITDA of NIS 24 Million,Strong Start to 2025

InterCureOriginal source
🇨🇦Devicesprofoundmedical.comTier 1 · Company source

Profound Medical to Participate in the 2025 Bloom Burton & Co. Healthcare Investor Conference

Profound MedicalOriginal source
🌍Industryintercure.coTier 1 · Company source

FORM 20-F

InterCureOriginal source
🇨🇦Devicesprofoundmedical.comTier 1 · Company source

Initial Perioperative Data from CAPTAIN Randomized Trial Demonstrate MRI-Guided TULSA Provides Statistically Significant Improvement of Post-Operative Experience Vs. Robotic Radical Prostatectomy

Profound MedicalOriginal source
🇨🇦Devicesprofoundmedical.comTier 1 · Company source

Initial Perioperative Data from CAPTAIN Randomized Trial Demonstrate MRI-Guided TULSA Provides Statistically Significant Improvement of Post-Operative Experience Vs. Robotic Radical Prostatectomy

Profound MedicalOriginal source
🇺🇸Industrycapsida.comTier 1 · Company source

Capsida to Present Progress Updates at the ASGCT Annual Meeting, Including NHP GLP Toxicology Study Results for its Potential First-in-Class STXBP1 Developmental and Epileptic Encephalopathy Program (CAP-002 STXBP1-DEE)

Capsida BiotherapeuticsOriginal source
🌍Industryoramed.comTier 1 · Company source

Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical

Oramed PharmaceuticalsOriginal source
🇪🇬Researchcu.edu.egTier 2 · Direct publisher

Kasr Al Aini lance le programme de médecinefrançaise « KAF » en 2025-2026 : une étapestratégique pour promouvoir le leadership africain et l’ouvertureinternationale.

Cairo UniversityOriginal source
🇺🇸Industrybeamtx.comTier 1 · Company source

saved jobs

Beam TherapeuticsOriginal source
🇺🇸Devicesnatus.comTier 1 · Company source

6 reasons emergency departments should consider point of care eeg

Natus Medical (ArchiMed Group)Original source
🌍Industrynimbustx.comTier 1 · Company source

Nimbus Therapeutics Announces Initiation of First-in-Human Clinical Trial with NDI-219216, Novel WRN Inhibitor for MSI-H Tumors

Nimbus TherapeuticsOriginal source
🇺🇸Industryclinicalink.comTier 1 · Company source

Clinical ink Launches TrialLens™: An AI-Powered Operations Dashboard for eCOA and Connected Device Trials

Clinical InkOriginal source
🌍Industryxoma.comTier 1 · Company source

2025 Letter to Stockholders

Xoma CorporationOriginal source
🌍Industrydayonebio.comTier 3 · Secondary coverage

Giving New Life to Medicines – and New Options to Patients Fighting Cancer

Mersana TherapeuticsOriginal source
🌍Industrycytomx.comTier 1 · Company source

An mRNA-encoded masked IL-12 improves systemic tolerability while maintaining anti-tumor efficacy in preclinical studies

CytomX TherapeuticsOriginal source
🇧🇷Researchpharlab.com.brTier 2 · Direct publisher

COMUNICADO: Gardenal, Frisium e Urbanil

Pharlab (Brazil News)Original source
🇺🇸Devicesparagon28.comTier 1 · Company source

Zimmer Biomet Completes Acquisition of Paragon 28

Paragon 28Original source
🌍Regulatoryacrohealth.orgTier 1 · Regulatory source

Good Clinical Podcast Season 3

ACRO AssociationOriginal source
🇺🇸Industrybeamtx.comTier 1 · Company source

Current Openings | Beam Therapeutics

Beam TherapeuticsOriginal source
🇩🇪Mediadzne.deTier 2 · Direct publisher

Hereditary Alzheimer’s: Blood Marker for Defective Neuronal Connections Rises Early

DZNE (Neurodegenerative Diseases)Original source
🇺🇸Devicesfoundationmedicine.comTier 1 · Company source

A Milestone in Advancing Cancer Care: 1,000 Peer-Reviewed Publications and Counting

Foundation MedicineOriginal source
🇩🇪Mediadzne.deTier 2 · Direct publisher

EU Authorizes Alzheimer‘s Drug “Lecanemab”

DZNE (Neurodegenerative Diseases)Original source
🇮🇹CDMOflammagroup.comTier 2 · Direct publisher

Flamma Published in Organic Process Research & Development (OPRD): A new method for assessing eco-impact by using both quantitative and qualitative data, focusing on process sustainability

Flamma GroupOriginal source
🇨🇦Devicesprofoundmedical.comTier 1 · Company source

Profound Medical AUA 2025 Investor Event Agenda

Profound MedicalOriginal source
🌍Regulatoryravimiamet.eeTier 1 · Regulatory source

Statistical Overview of Human and Veterinary Medicines for 2024

SAM EstoniaOriginal source
🇺🇸Industryordaos.bioTier 1 · Company source

using-deep-learning-to-discover-functional-antibodies-for-sars-cov-2-with-picomolar-binding-affinity

Ordaos BioOriginal source
🇺🇸Industryordaos.bioTier 1 · Company source

deep-learning-based-protein-therapeutics-design-to-treat-her2-cancers

Ordaos BioOriginal source
🇫🇷Researchsorbonne-universite.frTier 2 · Direct publisher

Recherche et Patrimoine culturel : Signature d’une convention partenariale entre Sorbonne Université et l’Assemblée nationale dans le cadre du projet « Delacroix numérique »

Sorbonne UniversityOriginal source
🇪🇬Researchcu.edu.egTier 2 · Direct publisher

A momentous occasion unfolded at Cairo University Grand Celebration Hall, where the Egyptian-French Universities Forum was hosted, with French President Emmanuel Macron present.

Cairo UniversityOriginal source
🌍Regulatoryravimiamet.eeTier 1 · Regulatory source

State Agency of Medicines Successfully Passes International Audit, Ranking Among the Top EU Regulatory Agencies

SAM EstoniaOriginal source
🇺🇸CDMOkbibiopharma.comTier 2 · Direct publisher

KBI Biopharma Awarded as Global Leader in Biologics Manufacturing

KBI BiopharmaOriginal source
🇺🇸CDMOfmcbiopolymer.comTier 2 · Direct publisher

Glycan-Based Treatments: Exploring the Capabilities of Glycan Biology in Modern Medicine

FMC BiopolymerOriginal source
🇺🇸CDMOfmcbiopolymer.comTier 2 · Direct publisher

Innovations in Glycosylation Pathways: Shaping the Advancement of Biotechnological Production and Therapeutics

FMC BiopolymerOriginal source
🇺🇸Industrycapsida.comTier 1 · Company source

Capsida Presents New Data from GLP Toxicology Study in NHPs Demonstrating Potential Best-in-Class Profile of CAP-003 in Patients with Parkinson’s Disease Associated with GBA Mutations (PD-GBA)

Capsida BiotherapeuticsOriginal source
🇺🇰Industrygenialcompliance.comTier 3 · Secondary coverage

Genial's Step-by-Step Guide for Preparing for Laboratory Inspections to Achieve and Maintain Accreditation - Genial

Genial Genetics (Pathozoom AI)Original source
🇺🇸Industryordaos.bioTier 1 · Company source

Scrip Asks…What Does 2023 Hold For Biopharma? Part 6: Artificial Intelligence

Ordaos BioOriginal source
🇺🇸Industryordaos.bioTier 1 · Company source

Ordaōs Opens Lab Space in JLABS@NYC

Ordaos BioOriginal source
🇺🇸Industryordaos.bioTier 1 · Company source

Ordaõs Looks To Unlock The Therapeutic Promise Of Mini-Proteins

Ordaos BioOriginal source
🇺🇸Industryordaos.bioTier 1 · Company source

ChatGPT Is Just The 'Tip Of The Iceberg' In Content-Creating Artificial Intelligence; Get Ready For 'A Lot Of Disruption'

Ordaos BioOriginal source
🇺🇸Industryordaos.bioTier 1 · Company source

Ordaōs Uses AI to Generate Therapeutic Mini-Proteins

Ordaos BioOriginal source
🇺🇸Industryordaos.bioTier 1 · Company source

AI has secured a footing in drug discovery. Where does it go from here?

Ordaos BioOriginal source
🇺🇸Industryordaos.bioTier 1 · Company source

Ordaōs Selected to Participate in the AWS Generative AI Accelerator

Ordaos BioOriginal source
🇺🇸Industryordaos.bioTier 1 · Company source

Can drug design replace drug discovery? Current JLABS resident Ordaos thinks so and explains how

Ordaos BioOriginal source
🇺🇸Industryordaos.bioTier 1 · Company source

Ordaōs and FatiAbGen Partner to Optimize Therapeutics for Challenging Oncology Conditions

Ordaos BioOriginal source
🇺🇸Industryordaos.bioTier 1 · Company source

The Generative AI Revolution is Creating The Next Phase Of Autonomous Enterprise

Ordaos BioOriginal source
🇺🇸Industryordaos.bioTier 1 · Company source

Ordaōs Announces a Joint Development Agreement to Create Novel Therapeutics for AML

Ordaos BioOriginal source
🇺🇸Industryordaos.bioTier 1 · Company source

Ordaōs Announces Appointment of Ziwei Liang, PhD to Role of Chief Science Officer

Ordaos BioOriginal source
🇺🇸Industryordaos.bioTier 1 · Company source

Ordaōs/NonExomics Deal Shines Light on Novel Mini-Proteins

Ordaos BioOriginal source
🇺🇸Industryordaos.bioTier 1 · Company source

Ordaōs and NonExomics Announce Research Collaboration

Ordaos BioOriginal source
🇺🇸Industryordaos.bioTier 1 · Company source

Mini-Proteins Combine Best of Monoclonals and Small-Molecule Drugs

Ordaos BioOriginal source
🇺🇸Industryordaos.bioTier 1 · Company source

Ordaōs Raises $5 Million in Seed to Accelerate Drug Design and Discovery

Ordaos BioOriginal source
🇺🇸Industryordaos.bioTier 1 · Company source

Vyant Bio, Inc., Ordaōs Bio, and Cellaria, Inc. Announce Collaboration to Design and Qualify Biomarker-Specific Small Protein Therapeutics

Ordaos BioOriginal source
🇺🇸Researchforesitecapital.comTier 2 · Direct publisher

Sollis Health: Redefining Urgent and Emergency Care

Foresite CapitalOriginal source
🌍Industrycerbios.swissTier 3 · Secondary coverage

HAS acquires Cerbios-Pharma SA

Cerbios-Pharma SAOriginal source
🇮🇹CDMOflammagroup.comTier 2 · Direct publisher

Flamma Awarded Best On-Time Delivery at 2025 CDMO Leadership Awards

Flamma GroupOriginal source
🇺🇸CDMOadarepharmasolutions.comTier 3 · Secondary coverage

Adare Honored with 2025 Outsourced Pharma CDMO Leadership Award

Adare PharmaceuticalsOriginal source
🇩🇪Mediadzne.deTier 2 · Direct publisher

Intermittent Fasting Increases Sex Drive in Male Mice: An Approach for Low Libido in Humans?

DZNE (Neurodegenerative Diseases)Original source